Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: Bone Marrow Transplant. 2011 Nov 14;47(8):1051–1055. doi: 10.1038/bmt.2011.217

Figure 2.

Figure 2

Mobilization response and total CD34+ cells/kg yield following preemptive dosing of plerixafor given on day 5, 6 and 7 of G-CSF treatment. * indicates patient who did not undergo apheresis due to lack of venous access.